Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine
Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine
复制标题
抑制 YAP 信号传导导致四甲基吡嗪诱导的肝星状细胞衰老
DOI:
10.1016/j.ejps.2016.10.002
复制
发表时间:
2017-01-01
影响因子:
4.6
通讯作者:
Zheng, Shizhong
中科院分区:
文献类型:
--
作者:
Jin, Huanhuan;Lian, Naqi;Zheng, Shizhong
Accumulating evidence indicates that hepatic stellate cells (HSCs) are the central mediators and major effectors in the development of hepatic fibrosis. It iswell-known that regulation of cell proliferation and apoptosis are potential strategies to block the activation of HSCs. Recently, several studies have revealed that induction of HSC senescence could prevent and cure the liver fibrosis. In our previous work, we have demonstrated that the natural product tetramethylpyrazine (TMP) could inhibit the activation of HSCs and ameliorate hepatic fibrosis. The aim of this study was to identify a new role of TMP in the regulation of activated HSC senescence and to elucidate the underlying mechanisms. In this study, our data showed that TMP could promote HSC senescence in vivo and in vitro. Moreover, TMP affected the cell cycle and telomerase activity. We further demonstrated that P53 siRNA or P53 pharmacological inhibitor PFT-aabrogated the TMP-induced HSC senescence in vitro. Meanwhile, similar results were obtained in vivo. Further studies indicated that TMP promoted the expression of P53 through a YAP inhibition-dependent mechanism. Moreover, silencing YAP enhanced TMP induction of activated HSC senescence. Collectively, our results suggested that TMP inhibited the activation of HSCs by inducing senescence and had therapeutic implication for the treatment of liver fibrosis. (C) 2016 Elsevier B.V. All rights reserved.